EPRX Stock Summary and Trading Ideas (Eupraxia Pharmaceuticals | NASDAQ:EPRX)

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.

Eupraxia Pharmaceuticals trades on the NASDAQ stock market under the symbol EPRX.

As of May 9, 2024, EPRX stock price climbed to $2.93 with 51,160 million shares trading.

EPRX has a market cap of $104.37 million. This is considered a Micro Cap stock.

EPRX support price is $2.71 and resistance is $3.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EPRX stock will trade within this expected range on the day.